Biotechnology Stocks I Performance Guide: Sage Therapeutics, Inc. (SAGE)
SAGE has no dividends
Table and Chart of SAGE Performance
See what a $1,000 investment in SAGE is worth today.
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
| SAGE Returns | |
|---|---|
| Start Date | Aug-29-2014 |
| Start Price | $28.92 |
| End Date | Dec-01-2023 |
| End Price | $20.39 |
| # Prices | 113 |
| Min Date | Oct-31-2023 |
| Min Price | $18.73 |
| Max Date | Jan-31-2018 |
| Max Price | $189.80 |
| Total Return | -29.50% |
| Annualized Return | -3.64% |
| Current Value of $1,000 Purchase | $705 |
| Number Returns | 6,328 |
| Average Return | 21.90% |
| Number Profitable Returns | 2,782 |
| Percent Profitable Returns | 43.96% |
| Number Unprofitable Returns | 3,546 |
| Percent Unprofitable Returns | 56.04% |
| Profitable to Unprofitable Returns Ratio | 0.78 |
| SAGE Data | |
|---|---|
| VALUATION DATA | |
| Market Capitalization | $1,222,737,000 | Price to Sales | 107.75 |
| Earnings per Share | $-10.9800 |
| PE Ratio | None |
| PE to Growth Ratio | 0.74 |
| Price to Book | 1.497 |
| PRICE DATA | |
| 52 Week High | $59.99 |
| 52 Week Low | $16.52 |
| Analyst Target Price | $25.53 |
| 50-Day Moving Average | $19.35 |
| 200-Day Moving Average | $35.35 |
| FINANCIAL DATA | |
| Revenue per Share | $0.19 |
| Revenue | $11,348,000 |
| Profit Margin | 0% |
| Return on Equity | -0.597% |
| Stock Dividend, Valuation, Price and Financial Data Input | |
SAGE Compare Returns with S&P 500
SAGE Trendline Chart